U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Norris S, Weinstein J, Peterson K, et al. Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers: Final Report [Internet]. Portland (OR): Oregon Health & Science University; 2010 Jan.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers

Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers: Final Report [Internet].

Show details

Appendix EBlack box warnings for included drugs

Trade nameActive ingredientBlack box warnings
Tekturna®AliskirenWhen used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, drug should be discontinued as soon as possible.
Lotensil®Benazepril
Capoten®Captopril
Vasotec®Enalapril
Monopril®Fosinopril
Prinivil®Lisinopril
Zestril®Lisinopril
Univasc®Moexipril
Accupril®Quinapril
Altace®Ramipril
Aceon®Perindopril
Mavik®Trandolapril
Cozaar®Losartan
Micardis®Telmisartan
Atacand®Candesartan
Teveten®Eprosartan
Avapro®Irbesartan
Benicar®Olmesartan
Rasilez®AliskirenDrugs that act directly on the renin-angiotensin system can cause fetal and neonatal morbidity and death when administered to pregnant women. When pregnancy is detected, Rasilez should be discontinued as soon as possible.
Inhibace®CilazaprilWhen used in pregnancy, these drugs can cause injury or even death of the developing fetus. When pregnancy is detected, Inhibace should be discontinued as soon as possible.
Coversyl®Perindopril
Diovan®Valsartan
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.
Bookshelf ID: NBK47124

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.0M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...